The ALS Network has endorsed the revival of the Accelerating Access to Critical Therapies for ALS Act (H.R.8205) in Los Angeles on April 8, 2026. This act aims to expedite the development of treatments and potential cures for ALS. The reauthorization of the act is expected to contribute significantly in advancing research for ALS, a neurodegenerative disease. The ALS Network's support underscores the urgency of this bipartisan initiative in driving crucial advancements in this field.